Given recent macro and consumer data have been positive, Travis is a great recovery story on a 12-month view. It remains one of our top picks for 2006.

This is the kind of thing that happens with economic data. In any given month, you have random variations in price trends Those random changes tend to offset each other.

We view this as a critical event in the Pfizer story and a potential positive catalyst for the stock.

The recovery in employment and incomes should continue bolstering consumption ahead. And the recent machinery orders data suggests capital spending will maintain an uptrend into the fourth quarter onwards.

Almost every month we have 20 to 30 patients needing a recovery room.

You can tell a difference in them from the very first month. Once they have been given permission to be a woman, the depression lifts.